OVERVIEW

In-Person and Virtual attendance options are available. Presented by the Houston Methodist Neurological Institute

There have been significant advances in the diagnosis and treatment of many neurological diseases. Attempts to cover these scientific advances have been made through peer-reviewed journals, national and international society meetings, and consensus statements. This program will emphasize evidence-based strategy for the current treatment of neurological disorders and cutting-edge research in novel therapeutics.

TARGET AUDIENCE

This conference is designed for physicians, nurses, nurse practitioners, physician assistants, physical therapists, occupational therapists, speech-language therapists and residents/fellows in the neurological sciences will benefit from this course.

LEARNING OBJECTIVES

At the conclusion of this activity, the participant should be able to: 

• Apply new medical and surgical therapies for the treatment of neurological diseases
• Discuss new and future therapies for stroke, epilepsy, demyelinating diseases, headaches, Parkinson’s disease, and neuromuscular diseases
• Describe the diagnosis and treatment of dementias, vestibular dysfunction, stroke, and 

ACCREDITATION

• 14.75 AMA PRA Category 1 Credit™

  Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

  Houston Methodist designates this Live activity for a maximum of 14.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• 14.75 Attendance
• 15.00 Nursing Contact Hours

For more information please visit the official event oage.